Table 1.
Participant Characteristics by Cohort
Characteristics | ADHF (N=27) | Stable HFpEF (N=80) | Stable HFrEF (N=56) | Healthy (N=61) |
---|---|---|---|---|
Age (years) | 72 ± 10 | 71 ± 7 | 69 ± 5 | 69 ± 7 |
Women | 59%† | 80% | 34% | 62% |
Black | 56%* | 29% | 18% | 5% |
Body mass index (kg/m2) | 29.3±6.7* | 31.9±6.5 | 26.6±4.3 | 25.9±4.9 |
Left ventricular ejection fraction (%) | 37±16* | 62±7 | 32±10 | 66±7 |
Hypertension | 89%* | 88% | 52% | N/A |
Diabetes mellitus | 48%§ | 23% | 27% | N/A |
Ischemic heart disease | 63%† | 0% | 25% | N/A |
Diuretic | 100%† | 73% | 82% | N/A |
Beta-blocker | 85%† | 31% | 11% | N/A |
Angiotensin-converting-enzyme inhibitor or Angiotensin II receptor blocker | 59% | 53% | 79% | N/A |
Digoxin | 7%‡ | 1% | 71% | N/A |
Data presented as mean ± SD or percentage.
ADHF is significantly different from all 3 groups
ADHF is significantly different than HFREF and HFPEF
ADHF is significantly different than HFREF
ADHF is significantly different than HFPEF. Comparisons made using analysis of variance for continuous variables and Fisher's exact test for categorical variables.
Abbreviations: ADHF = acute decompensated heart failure; HFpEF = heart failure with preserved ejection fraction; HFrEF = heart failure with reduced ejection fraction; N/A = non-applicable